mRNA library preparation and sequencing were done at Genome ... Eight–10-week-old Pv Cre mice were injected with AAV-CAG-DIO-eGFP-eIF4E-shRNAmir or AAV-CAG-DIO-EGFP-scrambled-shRNAmir using a ...

To generate the construct for expressing EGFP-tagged Ptbp2 (EGFP-Ptbp2), the mouse Ptbp2 coding ... of hnRNP R in cultured motoneurons by regulating the association of Hnrnpr mRNA with translating ...

Developed by Moderna Pharmaceuticals-the same company that made headlines with its Covid-19 vaccine-the jab, known as mRNA-4359, is designed to activate the body's immune system to identify and ...

Sept. 13 (UPI) --A Florida health official is raising alarms about the safety of the newest versions of mRNA COVID-19 vaccines, advising against their use despite endorsements from federal health ...

The mRNA revolution continues. Just a few years after mRNA vaccines proved their efficacy against COVID-19, scientists are now turning their attention to lung cancer. The mRNA vaccine, known as ...

Using mRNA technology similar to Covid-19 vaccines, BNT116 aims to enable the immune system to target NSCLC tumour markers, attacking cancer cells while sparing healthy ones. Lung cancer is the ...

BioNTech has announced the initiation of global clinical trials for BNT116, an mRNA vaccine for the potential treatment of non-small cell lung cancer (NSCLC). The vaccine is claimed to use the ...

Moderna, Inc.'s combination flu and COVID-19 vaccine, mRNA-1083, showed strong Phase 3 results in adults over 50. Pfizer/BioNTech's combination vaccine faced setbacks, giving Moderna a potential ...